REFERENCES
- Goodwin F, Jamison K. Manic-depressive illness. Oxford University Press, New York 1990
- Mitchell P B, Malhi G S. The expanding pharmacopoeia for bipolar disorder. Annu Rev Med 2002; 53: 173–88, [INFOTRIEVE], [CSA]
- Bauer M S, Mitchner L. What is a “mood stabilizer”? An evidence-based response. Am J Psychiatry 2004; 161: 3–18, [INFOTRIEVE], [CROSSREF], [CSA]
- Xiaohua L, Ketter T A, Frye M A. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorder?. J Affect Disord 2002; 69: 1–14, [CROSSREF], [CSA]
- Suppes T, Baldessarini R J, Faedda G L, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 1082–8, [INFOTRIEVE], [CSA]
- Post R M, Leverich G S, Altshuler L, Mikalauskas K. Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 1992; 149: 1727–9, [INFOTRIEVE], [CSA]
- Faedda G L, Tondo L, Baldessarini R J, Suppes T, Tohen M. Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993; 50: 448–55, [INFOTRIEVE], [CSA]
- Yazici O, Kora K, Polat A, Saylan M. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis. J Affect Disord 2004; 80: 269–71, [INFOTRIEVE], [CROSSREF], [CSA]
- Maj M, Pirozzi R, Magliano L. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors. Am J Psychiatry 1995; 152: 1810–1, [INFOTRIEVE], [CSA]
- Tondo L, Baldessarini R J, Floris G, Rudas N. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry 1997; 154: 548–50, [INFOTRIEVE], [CSA]
- Coryell W, Solomon D, Leon A C, et al. Lithium discontinuation and subsequent effectiveness. Am J Psychiatry 1998; 155: 895–8, [INFOTRIEVE], [CSA]